Market Place
Sourcing Support
All News #Library
Others
Tolmar Introduces Care Partner Corner For Prostate Cancer Support
04 Feb 2026 //
PR NEWSWIRE
Rosalind Franklin University Welcomes Tolmar`s New Northern Site
16 Dec 2025 //
PR NEWSWIRE
Tolmar Collaborates With UpScriptHealth For Oral Testosterone Access
23 Oct 2024 //
PR NEWSWIRE
The pharma& Group Partners With Tolmar to Promote Rubraca® for mCRPC
24 Sep 2024 //
PR NEWSWIRE
Tolmar Announces Acquisition of JATENZO for the Treatment of Hypogonadism
27 Oct 2022 //
PRNEWSWIRE
Clarus Therapeutics Announces Completion of Auction for Sale of JATENZO
18 Oct 2022 //
GLOBENEWSWIRE
CMS Issues Permanent J-Code for Tolmar`s FENSOLVI Effective July 1, 2021
12 May 2021 //
PRNEWSWIRE
Tolmar Publishes Study in the February Issue of Journal of Urology on the Impact
13 Apr 2021 //
PRNESWIRE
Tolmar Publishes Study in the February Issue of Journal of Urology the Impact
13 Apr 2021 //
GLOBNEWSWIRE
Tolmar Affirms Supply of FENSOLVI® (leuprolide acetate) for Pediatric Patients
18 Aug 2020 //
PRNEWSWIRE
Tolmar Affirms Full Supply of Eligard® for Injectable Suspension Palliative
10 Aug 2020 //
PRNEWSWIRE
Real-World Data Analysis Published in the Journal of Urology- (LHRH) Dosing
18 May 2020 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.